Product Information
DOXYCYCLINE HYCLATE 150 MG TAB is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.7243 per EA under NDC 27241015402. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Jun 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241015402
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Generic (ANDA)
FDA Application
ANDA211584FDA Approved
6/1/2020
TE Code
AB
On Market Since
6/1/2020
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 14.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7243 per EA |
|---|---|
| All-time high | $0.9134 (Jun 10, 2026) |
| All-time low | $0.6076 (Oct 23, 2024) |
| 52-week high | $0.9134 |
| 52-week low | $0.6934 |
| Median price | $0.7595 |
| Average price | $0.7697 |
| Largest weekly change | -24.1% (Jun 17, 2026) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxycycline hyclate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline hyclate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE HYCLATE 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE HYCLATE 150 MG TAB, manufactured by Ajanta Pharma USA Inc., is $0.7243 per EA (NDC 27241015402), effective Sep 30, 2026.
How has the price of DOXYCYCLINE HYCLATE 150 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has risen 14.1%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE HYCLATE 150 MG TAB?
Since Jul 17, 2024, the NADAC for DOXYCYCLINE HYCLATE 150 MG TAB has ranged from a low of $0.6076 (Oct 23, 2024) to a high of $0.9134 (Jun 10, 2026), with a median of $0.7595 per EA.
Are there cheaper alternatives to DOXYCYCLINE HYCLATE 150 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DOXYCYCLINE HYCLATE 150 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXYCYCLINE HYCLATE 150 MG TAB?
DOXYCYCLINE HYCLATE 150 MG TAB (NDC 27241015402) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.